BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36345190)

  • 41. Trends in the Use of Adjuvant Chemotherapy for High-Grade Truncal and Extremity Soft Tissue Sarcomas.
    Squires MH; Ethun CG; Suarez-Kelly LP; Yu PY; Hughes TM; Shelby RD; Tran TB; Poultsides G; Charlson J; Gamblin TC; Tseng J; Roggin KK; Chouliaras K; Votanopoulos K; Krasnick BA; Fields RC; Pollock RE; Grignol V; Cardona K; Howard JH
    J Surg Res; 2020 Jan; 245():577-586. PubMed ID: 31494391
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical relevance of peroxisome proliferator-activated receptor-gamma expression in myxoid liposarcoma.
    Takeuchi A; Yamamoto N; Shirai T; Hayashi K; Miwa S; Munesue S; Yamamoto Y; Tsuchiya H
    BMC Cancer; 2016 Jul; 16():442. PubMed ID: 27401457
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Individualised risk assessment for local recurrence and distant metastases in a retrospective transatlantic cohort of 687 patients with high-grade soft tissue sarcomas of the extremities: a multistate model.
    Willeumier JJ; Rueten-Budde AJ; Jeys LM; Laitinen M; Pollock R; Aston W; Dijkstra PD; Ferguson PC; Griffin AM; Wunder JS; Fiocco M; van de Sande MA
    BMJ Open; 2017 Feb; 7(2):e012930. PubMed ID: 28196946
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A moderate dose of preoperative radiotherapy may improve resectability in myxoid liposarcoma.
    Lansu J; Braam PM; van Werkhoven E; Scholten AN; Schrage Y; van Houdt WJ; van Langevelde K; Haas RL
    Eur J Surg Oncol; 2021 Oct; 47(10):2633-2639. PubMed ID: 34233858
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic Factors and Outcomes for Patients With Myxofibrosarcoma: A 13-Year Retrospective Evaluation.
    Mühlhofer HML; Lenze U; Gersing A; Lallinger V; Burgkart R; Obermeier A; VON Eisenhart-Rothe R; Knebel C
    Anticancer Res; 2019 Jun; 39(6):2985-2992. PubMed ID: 31177139
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Localized extranodal lymphoma of the head and neck: retrospective analysis of a series of 107 patients from a single institution.
    Frata P; Buglione M; Grisanti S; Bonetti B; Vitali E; De Stefani A; Magri E; Peveri A; Marini G; Rossi G; Magrini SM
    Tumori; 2005; 91(6):456-62. PubMed ID: 16457141
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Radiotherapy for retroperitoneal liposarcoma: A report from the Transatlantic Retroperitoneal Sarcoma Working Group.
    Haas RLM; Bonvalot S; Miceli R; Strauss DC; Swallow CJ; Hohenberger P; van Coevorden F; Rutkowski P; Callegaro D; Hayes AJ; Honoré C; Fairweather M; Gladdy R; Jakob J; Szacht M; Fiore M; Chung PW; van Houdt WJ; Raut CP; Gronchi A
    Cancer; 2019 Apr; 125(8):1290-1300. PubMed ID: 30602058
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Solitary pancreatic metastasis of extremity myxoid liposarcoma: a case report and literature review.
    Wang D; Wu J; Yu J; Zhang H; Liu H
    BMC Cancer; 2018 Nov; 18(1):1121. PubMed ID: 30445938
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Influence of age and subtype in outcome of operable liposarcoma.
    Greto D; Saieva C; Loi M; Terziani F; Visani L; Garlatti P; Lo Russo M; Muntoni C; Becherini C; Topulli J; Campanacci D; Beltrami G; Scoccianti G; Muratori F; Bonomo P; Desideri I; Francolini G; Livi L
    Radiol Med; 2019 Apr; 124(4):290-300. PubMed ID: 30421387
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neoadjuvant image-guided helical intensity modulated radiotherapy of extremity sarcomas - a single center experience.
    Peeken JC; Knie C; Kessel KA; Habermehl D; Kampfer S; Dapper H; Devecka M; von Eisenhart-Rothe R; Specht K; Weichert W; Wörtler K; Knebel C; Wilkens JJ; Combs SE
    Radiat Oncol; 2019 Jan; 14(1):2. PubMed ID: 30626408
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of outcome and prognostic factors in thoracic primitive neuroectodermal tumor: a study of 84 cases.
    Biswas B; Agarwala S; Shukla NK; Deo S; Sharma D; Thulkar S; Vishnubhatla S; Bakhshi S
    Ann Thorac Surg; 2013 Dec; 96(6):2006-14. PubMed ID: 24035307
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Management of soft tissue sarcomas in first isolated local recurrence: a retrospective study of 83 cases].
    Moureau-Zabotto L; Thomas L; Bui BN; Chevreau C; Stockle E; Martel P; Bonneviale P; Marques B; Coindre JM; Kantor G; Matsuda T; Delannes M
    Cancer Radiother; 2004 Oct; 8(5):279-87. PubMed ID: 15561593
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adjuvant radiotherapy for margin-positive high-grade soft tissue sarcoma of the extremity.
    Alektiar KM; Velasco J; Zelefsky MJ; Woodruff JM; Lewis JJ; Brennan MF
    Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):1051-8. PubMed ID: 11072162
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic factors and outcome of Liposarcoma patients: a retrospective evaluation over 15 years.
    Knebel C; Lenze U; Pohlig F; Lenze F; Harrasser N; Suren C; Breitenbach J; Rechl H; von Eisenhart-Rothe R; Mühlhofer HML
    BMC Cancer; 2017 Jun; 17(1):410. PubMed ID: 28606068
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of prognostic factors affecting survival in chondrosarcoma treatment and comparison with literature.
    Coşkun HS; Erdoğan F; Büyükceran İ; Dabak N
    Jt Dis Relat Surg; 2022; 33(2):440-448. PubMed ID: 35852206
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Liposarcoma: outcome based on the Scandinavian Sarcoma Group register.
    Engström K; Bergh P; Gustafson P; Hultborn R; Johansson H; Löfvenberg R; Zaikova O; Trovik C; Wahlström O; Bauer HC
    Cancer; 2008 Oct; 113(7):1649-56. PubMed ID: 18720363
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Does adjuvant radiation therapy increase loco-regional control after optimal resection of soft-tissue sarcoma of the extremities?
    Khanfir K; Alzieu L; Terrier P; Le Péchoux C; Bonvalot S; Vanel D; Le Cesne A
    Eur J Cancer; 2003 Sep; 39(13):1872-80. PubMed ID: 12932665
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The role of neoadjuvant radiochemotherapy in the management of localized high-grade soft tissue sarcoma.
    Kobus M; Roohani S; Ehret F; Flörcken A; Striefler JK; Brandes F; Märdian S; Rau D; Wittenberg S; Öllinger R; Kaul D
    Radiat Oncol; 2022 Aug; 17(1):139. PubMed ID: 35941656
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Liposarcoma: exploration of clinical prognostic factors for risk based stratification of therapy.
    Kim HS; Lee J; Yi SY; Jun HJ; Choi YL; Ahn GH; Seo SW; Lim DH; Ahn YC; Park JO; Kim SJ
    BMC Cancer; 2009 Jun; 9():205. PubMed ID: 19558664
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Solitary breast metastasis from myxoid liposarcoma.
    Yokouchi M; Nagano S; Kijima Y; Yoshioka T; Tanimoto A; Natsugoe S; Komiya S
    BMC Cancer; 2014 Jul; 14():482. PubMed ID: 24994066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.